Compugen Earnings Estimates, EPS & Revenue | NASDAQ:CGEN

Comments

Compugen Ltd Earnings Estimates

CGENNASDAQ

Trade with Public

$2.27

0.031.34%

At close: Mar 16, 5:00 PM EST

$2.30

0.031.32%

After Hours: 4:26 PM EST

Overview NewsEarningsOptions Analyst Ratings Short Interest Stock Report

Compugen Earnings Estimates, EPS & Revenue | NASDAQ:CGEN

Compugen (CGEN) is scheduled to report Q1 earnings on May 18, 2026. Analysts estimate EPS of $-0.08 and quarterly revenue of $1.78M.

In the most recent quarter (Q4), Compugen reported EPS of $0.60, beating estimates of $0.10 by 5.00%. Revenue came in at $67.33M, exceeding the estimate of $15.73M by 3.28%.

Compugen has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Compugen has averaged an EPS surprise of 1.46% and a revenue surprise of 1.17%.

Earnings Date

May 18

EPS Estimate

$-0.080

Quarterly Revenue Estimate

$1.78M

Annual Revenue
(as of Dec 31)

$72.76M

Compugen Earnings History

Analyze the earnings history of Compugen using advanced sorting and filters.

Loading calendar...

Compugen (CGEN) Earnings Per Share

The chart below shows Compugen's reported EPS compared to analyst estimates over recent quarters.

Compugen (CGEN) Revenue

The chart below shows Compugen's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Compugen (NASDAQ:CGEN) reporting earnings?

Compugen (CGEN) is scheduled to report earnings on May 18, 2026. The last reported earnings were for reported on March 2, 2026 for Q4.

What were the latest earnings per share (EPS) for Compugen (NASDAQ:CGEN)?

The Actual EPS was $0.60, which beat the estimate of $0.10.

What were Compugen’s (NASDAQ:CGEN) revenues?

The Actual Revenue was $67.33M, which beat the estimate of $15.73M.

People Also Watch

Galectin Therapeutics Inc

NASDAQ:GALT

$3.07

3.26%

Atrium Therapeutics Inc

NASDAQ:RNA

$13.80

0.04%

Zentalis Pharmaceuticals Inc

NASDAQ:ZNTL

$2.71

-0.18%

ProQR Therapeutics NV

NASDAQ:PRQR

$1.80

-4.17%

Elicio Therapeutics Inc

NASDAQ:ELTX

$10.90

-1.01%

Anika Therapeutics Inc

NASDAQ:ANIK

$14.20

1.13%

Compugen Earnings Estimates, EPS & Revenue | NASDAQ:CGEN

Compugen (CGEN) is scheduled to report Q1 earnings on May 18, 2026. Analysts estimate EPS of $-0.08 and quarterly revenue of $1.78M.

In the most recent quarter (Q4), Compugen reported EPS of $0.60, beating estimates of $0.10 by 5.00%. Revenue came in at $67.33M, exceeding the estimate of $15.73M by 3.28%.

Compugen has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Compugen has averaged an EPS surprise of 1.46% and a revenue surprise of 1.17%.

Earnings Date

May 18

EPS Estimate

$-0.080

Quarterly Revenue Estimate

$1.78M

Annual Revenue
(as of Dec 31)

$72.76M